One BioMed, a Singapore-based medical diagnostics company, on Wednesday announced that it has closed a $5 million Series A financing round led by Singapore-based Biopath Ventures and US-based ARCH Venture Partners.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
